Skip to main content
TipRanks
Go Ultimate75% OFF

Roche Holding AG (0QOK) Share Price & Analysis

34 Followers

0QOK Stock Chart & Stats

CHF 404.31-CHF 1.96(-0.48%)
At close: 4:30 PM GMT
CHF350CHF375CHF400Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
CHF 402.30 - CHF 406.50
52-Week Range
CHF 283.70 - CHF 407.60
Previous Close
CHF 406.27
Volume
N/A
Average Volume (3M)
283.10K
Market Cap
CHF 322.77B
Enterprise Value
CHF 294.66B
Total Cash (Recent Filing)
CHF 9.73B
Total Debt (Recent Filing)
CHF 31.80B
Price to Earnings (P/E)
26.3
Beta
0.96
Next Earnings
Jan 28, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
2.35%

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Roche’s strong operating and free cash flow provides substantial internal funding for research, acquisitions, dividends, and debt management. High free-cash-flow conversion also supports earnings quality and gives the company resilience to absorb pipeline investment or temporary operating pressure.

Margin Expansion

Operating profit growing faster than sales indicates meaningful operating leverage and improving efficiency across the business. If sustained, the margin expansion can strengthen earnings durability, support continued investment in innovation, and provide protection against moderate pricing or competitive pressure.

Pipeline And Portfolio Momentum

Regulatory progress and strong late-stage trial execution improve Roche’s ability to replenish and broaden its product portfolio. A diversified pipeline across oncology, immunology, neuroscience, and other areas can support future growth and reduce reliance on any single established franchise.

Bears Say

Loss-of-Exclusivity Pressure

Expected loss of exclusivity creates a continuing revenue and profit headwind as mature medicines face generic or biosimilar competition. Even with pipeline launches, Roche must replace this erosion through new indications, volume growth, and successful commercialization of newer therapies.

China Diagnostics Weakness

China’s pricing reform can pressure both demand and realized pricing in Roche’s diagnostics business, making recovery dependent on policy evolution and customer adaptation. A prolonged effect would weigh on the division’s growth and could limit its ability to offset weakness in other testing markets.

Higher Net Debt

The increase in net debt reduces financial flexibility relative to Roche’s prior position, particularly while the company continues funding dividends, acquisitions, and research. Although cash generation is strong, a larger debt burden can constrain capital allocation and increase sensitivity to future cash-flow volatility.

Roche Holding AG News

0QOK FAQ

What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest share price was CHF283.70 and its highest was CHF407.60 in the past 12 months.
What is Roche Holding AG’s market cap?
Roche Holding AG’s market cap is CHF322.77B.
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s next earnings report is estimated for Jan 28, 2027 (not yet confirmed), which is in 74 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Jul 23, 2026. The company reported CHF10.85 earnings per share for the quarter, beating the consensus estimate of CHF10.33 by CHF0.52.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Overvalued.
Does Roche Holding AG pay dividends?
Roche Holding AG does not currently pay dividends.
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is 9.70.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 702,562,700 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of CHF10.85 in its last earnings report, beating expectations of CHF10.33. Following the earnings report the stock price went up 2.553%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in GB:0QOK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology